Illumina share price drops as Roche's takeover attempts hit a wall

Article Date: 13/04/2012 10:00
Illumina share price drops as Roche's takeover attempts hit a wall

Vacancy Search

Quick job search

Advanced Search

Latest News

NICE backs new hep C, melanoma drugs

NICE backs new hep C, melanoma drugs

Auxilium adopts poison pill to block Endo bid

Auxilium adopts poison pill to block Endo bid

Merck Serono signs deals with Sutro, Lupin

Merck Serono signs deals with Sutro, Lupin

Merck & Co licences late-stage psoriasis drug to Sun

Merck & Co licences late-stage psoriasis drug to Sun

Gilead's simtuzumab fails pancreatic cancer trial

Gilead's simtuzumab fails pancreatic cancer trial

Sanofi $200M genetic heart disease pact with MyoKardia

Sanofi $200M genetic heart disease pact with MyoKardia

Endo looks to acquire Auxilium in $2.2 billion deal

Endo looks to acquire Auxilium in $2.2 billion deal

Esmo preview – Immuno-oncology and beyond

As the European Society of Medical Oncology, Europe’s answer to Asco, unveiled the abstracts to be presented at its annual congress today it was clear that PD-1/PD-L1 inhibition is set to be...

Lilly sells failed cancer drug enzastaurin to Denovo

Lilly sells failed cancer drug enzastaurin to Denovo

Pfizer buys into potential of GDNF for Parkinson's

Pfizer buys into potential of GDNF for Parkinson's
more news